Agent Orange, prostate cancer irradiation and acute promyelocyic leukemia (APL): Is there a link?

Leukemia Research

Volumn 31, Issue 5, 2007, Pages 720-721

  Atallah, Ehab ^a   Schiffer, Charles A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,5 TRICHLOROPHENOXYACETIC ACID;

ADULT; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CHROMOSOME ANALYSIS; DEEP VEIN THROMBOSIS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; VETERAN;

2,4,5-TRICHLOROPHENOXYACETIC ACID; 2,4-DICHLOROPHENOXYACETIC ACID; DEFOLIANTS, CHEMICAL; ENVIRONMENTAL EXPOSURE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; PROSTATIC NEOPLASMS; TETRACHLORODIBENZODIOXIN; VIETNAM; WAR;

EID: 34147180942     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.06.025     Document Type: Letter

References (8)

1. Frumkin H. Agent Orange and cancer: an overview for clinicians. CA Cancer J Clin 53 (2003) 245-255
2. Beaumont M., Sanz M., Carli P.M., et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 21 (2003) 2123-2137
3. Brenner D.J., Curtis R.E., Hall E.J., and Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
4. Schmidt C.K., Hoegberg P., Fletcher N., et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the endogenous metabolism of all-trans-retinoic acid in the rat. Arch Toxicol 77 (2003) 371-383
5. Schwarz M., and Appel K.E. Carcinogenic risks of dioxin: mechanistic considerations. Regul Toxicol Pharmacol 43 (2005) 19-34
6. Whitlock Jr. J.P. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39 (1999) 103-125
7. Bock K.W., and Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol (2006)
8. Giri V.N., Cassidy A.E., Beebe-Dimmer J., et al. Association between Agent Orange and prostate cancer: a pilot case-control study. Urology 63 (2004) 757-760